SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-23-011629
Filing Date
2023-04-28
Accepted
2023-04-28 16:15:16
Documents
10
Period of Report
2023-06-21

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A pirs20230119_def14a.htm DEF 14A 726467
2 capvnet.jpg GRAPHIC 56030
3 capvtsr.jpg GRAPHIC 58437
4 card_page1.jpg GRAPHIC 136888
5 card_page2.jpg GRAPHIC 178227
6 pirs20230119_def14aimg001.jpg GRAPHIC 3390
7 pirs20230119_def14aimg002.jpg GRAPHIC 2110
8 pirs20230119_def14aimg003.jpg GRAPHIC 2876
9 pirs20230119_def14aimg004.jpg GRAPHIC 2638
10 pirs20230119_def14aimg005.jpg GRAPHIC 3110
  Complete submission text file 0001437749-23-011629.txt   1339040
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37471 | Film No.: 23866386
SIC: 2834 Pharmaceutical Preparations